Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus

Diabetes and Metabolism

Volumn 34, Issue 1, 2008, Pages 75-81

  Ybarra, J ^a   Lehmann, T N O ^b   Golay, A ^b   Juge Aubry, C E ^c   Roux Lombard, P ^b   Dayer, J M ^b   Meier, C A ^c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Service of Endocrinology   (Switzerland)

Author keywords

Adiponectin; Cytokines; IL 1Ra; Leptin; Obesity; Type 2 diabetes

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LEPTIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; DIABETES EDUCATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TRAINING;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LEPTIN; MALE; MIDDLE AGED; PATIENT SELECTION; SEX CHARACTERISTICS;

EID: 39149104325     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.10.006     Document Type: Article

References (39)

1. Juge-Aubry C.E., Henrichot E., and Meier C.A. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metabol 19 (2005) 547-566
2. Jager J., Gremeaux T., Cormont M., Le Marchand-Brustel Y., and Tanti J.F. Interleukin-1, beta-induced insulin resistance in adipocytes through down-regulation of IRS-1 expression. Endocrinology 148 (2007) 241-251
3. Juge-Aubry C.E., Somm E., Giusti V., Pernin A., Chicheportiche R., Verdumo C., et al. Adipose tissue is a major source of interleukin-1 receptor antagonist. Upregulation in obesity and inflammation. Diabetes 52 (2003) 1104-1110
4. Meier C.A., Bobbioni E., Gabay C., Assimacopoulos-Jeannet F., Golay A., and Dayer J.M. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?. J Clin Endocrinol Metab 87 (2002) 1184-1188
5. Matsuki T., Horai R., Sudo K., and Iwakura Y. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med 198 (2003) 877-878
6. Maedler K., and Donath M.Y. Beta-cells in type 2 diabetes: a loss of function and mass. Horm Res 62 (2004) 67-73
7. Maedler K., Schumann D.M., Sauter N., Ellingsgaard H., Bosco D., Baertschiger R., et al. Low concentration of interleukin-1(beta) induces FLICE-inhibitory protein-mediated (beta)-cell proliferation in human pancreatic islets. Diabetes 55 (2006) 2713-2722
8. Somm E., Cettour-Rose P., Asensio C., Charollais A., Klein M., Theander-Carrillo C., et al. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia 49 (2006) 387-393
9. Marculescu R., Endler G., Schillinger M., Iordanova N., Exner M., Hayden E., et al. Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes 51 (2002) 3582-3585
10. Larsen C.M., Faulenbach M., Vaag A., Vølund A., Ehses J.A., Seifert B., et al. Interleukin-1 receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356 (2007) 1517-1526
11. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17 (2006) 4-12
12. Ronti T., Lupattelli G., and Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol 64 (2006) 355-365
13. Arner P. Insulin resistance in type 2 diabetes: role of the adipokines. Curr Mol Med 5 (2005) 333-339
14. Youn B.S., Min S.S., Park K.S., Lee H.W., Yu R., and Kwon B.S. The role of adipocytokines in adipocyte-related pathological processes. Drugs News Perpect 17 (2004) 293-298
15. Duncan B.B., Schmidt M.I., Pankow J.S., Bang H., Couper D., Ballantyne C.M., et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53 (2004) 2473-2478
16. Gil-Campos M., Canete R.R., and Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23 (2004) 963-974
17. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83 (1995) 1263-1271
18. Bobbioni-Harsch E., Assimacopoulos-Jeannet F., Lehmann T., Munger R., Allaz A.F., and Golay A. Leptin plasma levels as a marker of sparing-energy mechanisms in obese women. Int J Obes 23 (1999) 470-475
19. Gui Y., Silha J.V., and Murphy L.J. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res 12 (2004) 1481-1491
20. Weigle D.S., Duell P.B., Connor W.E., Steiner R.A., Soules M.R., and Kuijper J.L. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 82 (1997) 561-565
21. Haffner S.M., Stern M.P., Miettinen H., Wei M., and Gingerich R.L. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 45 (1996) 822-824
22. Tuttle H.A., Davis-Gorman G., Goldman S., Copeland J.G., and McDonagh P.F. Proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease. J Diabetes Complications 18 (2004) 343-351
23. Recasens M., Ricart W., and Fernandez-Real J.M. Obesity and inflammation. Rev Med Univ Navarra 48 (2004) 49-54
24. Diamant M., Lamb H.J., van de Ree M.A., Endert E.L., Groeneveld Y., Bots M.L., et al. The assocation between abdominal visceral fat and carotid artery stiffness is mediated by circulating inflammatory marker in uncomplicated Type 2 Diabetes. J Clin Endocrinol Metab 90 (2005) 1495-1501
25. Golay A., Bloise D., and Maldonato A. The education of people with diabetes. In: Pickup J.C., and Williams G. (Eds). Textbook of diabetes 1. 3rd ed (2003), Blackwell Publishing, Oxford 1-13 ch. 8
26. Painot D., Jotterand S., Kammer A., Fossati M., and Golay A. Simultaneous nutritional cognitive-behavioural therapy in obese patients. Patient Educ Counsel 42 (2001) 47-52
27. Burger D., and Dayer J.M. IL-1Ra. In: Oppenheim J.J., and Feldmann M. (Eds). Cytokine Reference (2000), Academic Press, New York 319-336
28. Saltiel A.E. You are what you secrete. Nat Med 7 (2001) 887-888
29. Rajala M.W., and Scherer P.E. Minireview: the adipocyte at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144 (2003) 3765-3773
30. Cullup H., Middleton P.G., Duggan G., Conn J.S., and Dickinson A.M. Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals. Clin Exp Immunol 137 (2004) 351-358
31. Sadeghi M., Daniel V., Naujokat C., Weimer R., and Opelz G. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?. Clin Exp Immunol 142 (2005) 312-317
32. Monzillo L.U., Hamdy O., Horton E.S., Ledbury S., Mullooly C., Jarema C., et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 11 (2003) 1048-1054
33. Paolisso G., Rizzo M.R., Mone C.M., Tagliamonte M.R., Gambardella A., Riondino M., et al. Plasma sex hormones are significantly associated with plasma leptin concentration in healthy subjects. Clin Endocrinol 48 (1998) 291
34. Deepa R., Velmurugan K., Arvind K., Sivaram P., Sientay C., Uday S., et al. Serum levels of interleukin-6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance: the Chennai urban rural epidemiology study (CURES). Metabolism 55 (2006) 1232-1238
35. Fernandez-Real J.M., Lopez-Bermejo A., Casamitjana R., and Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory processes. J Clin Endocrinol Metab 88 (2003) 2714-2718
36. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., et al. The origins of age-related pro-inflammatory state. Blood 105 (2005) 2294-2299
37. Zoico E., Di Francesco V., Mazzali G., Vettor R., Fantin F., Bissoli L., et al. Adipocytokines, fat distribution, and insulin resistance in elderly men and women. J Gerontol A Biol Sci Med Sci 59 (2004) M935-M939
38. Yannakoulia M., Yiannakouris N., Bluher S., Matalas A.L., Klimis-Zacas D., and Mantzoros C.S. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88 (2003) 1730-1736
39. Thorand B., Baumert J., Doring A., Herder C., Kolb H., Rathmann W., et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184 (2006) 216-224